Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy
Clinical trial NCT06399289 · COMPLETED
Trial details
- NCT number
- NCT06399289
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-28
- Primary completion
- 2026-07-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.